Aug 12 2024 9 mins 1
Visit https://www.peervoice.com/JRP860 to view the entire programme with slides. After completing “Ravi Ramjeesingh, MD, PhD, FRCPC - Immunotherapy for Biliary Tract Cancers: Changing the Narrative in Rare and Aggressive Tumours”, participants will be able to: Discuss prognosis and unmet needs in biliary tract cancers (BTCs); and Evaluate the evidence with immunotherapy-based regimens in BTCs and the clinical implications for care in Canada.
